6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9 Kemurnian ≥99.0% Favipiravir Intermediate COVID-19

Katrangan singkat:

Jeneng: 6-Bromo-3-Hydroxypyrazine-2-Carboxamide

CAS: 259793-88-9

Kemurnian: ≥99,0%

Intermediate Favipiravir (CAS 259793-96-9) ing perawatan infeksi virus Influenza lan COVID-19

Kualitas Tinggi, Produksi Komersial

Inquiry: alvin@ruifuchem.com

Kirimi email kanggo kita

Detail Produk

Produk sing gegandhengan

Tag produk

katrangan:

Produsen kanthi Kemurnian Tinggi lan Kualitas Stabil
Favipiravir Pasokan Komersial lan Perantara sing Gegandhengan:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Sifat Kimia:

Jeneng Kimia	6-Bromo-3-Hydroxypyrazine-2-Carboxamide
sinonim	Favipiravir Intermediate;Favipiravir Impurity 4
Nomer CAS	259793-88-9
Nomer CAT	RF-PI296
Status Simpenan	Ing Stok, Skala Produksi Nganti Atusan Kilogram
Formula Molekul	C5H4BrN3O2
Bobot Molekul	218.01
Merk	Kimia Ruifu

Spesifikasi:

Item	Spesifikasi
Penampilan	Cahya kuning nganti coklat bubuk
Identifikasi	IR, HPLC
Mundhut ing Pangatusan	≤1,0%
Sisa ing Ignition	≤0,20%
Impurity Tunggal	≤0,50%
Total Impurities	≤1,0%
Logam abot	≤20ppm
Sisa Solvents	Ketemu spesifikasi
Test Standar	Standar Perusahaan
Panggunaan	Intermediate Favipiravir (CAS 259793-96-9)

Paket & Panyimpenan:

Paket: Botol, tas Aluminium foil, Drum karton, 25kg / Drum, utawa miturut kabutuhan pelanggan.

Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya, kelembapan lan infestasi hama.

Kaluwihan:

FAQ:

Aplikasi:

6-Bromo-3-Hydroxypyrazine-2-Carboxamide (CAS 259793-88-9) minangka perantara biasane ing sintesis 6-Bromo-3-Hydroxypyrazine-2-Carboxamide kanthi jeneng komersial Favipiravir (CAS 259793-96-9) perawatan infeksi virus influenza.Rute praktis lan langkah-ekonomi menyang Favipiravir.Favipiravir minangka produk riset sing gegandhengan karo COVID19, kanggo perawatan pasien COVID-19 sing disaranake WHO.Favipiravir, uga dikenal minangka T-705 utawa Avigan, minangka obat antivirus sing dikembangake dening Toyama Chemical (Fujifilm Group) Jepang kanthi aktivitas nglawan akeh virus RNA.Favipiravir disetujoni kanggo marketing ing Jepang ing Maret 2014 lan digunakake kanggo perawatan antivirus influenza A lan B. Saliyane virus influenza, obat kasebut uga nuduhake aktivitas antivirus sing apik kanggo macem-macem virus RNA, kayata virus Ebola, virus pasir, Virus Bunia, virus rabies, lsp. Ing Februari 2020 Favipiravir lagi diteliti ing China kanggo perawatan eksperimen penyakit COVID-19 (Novel Coronavirus) sing muncul lan wis nuduhake asil sing positif.